EP3883606

JANSSEN BIOTECH
Application Number
EP19867085A
Filing Date
Sep 24, 2019
Status
Granted And Under Opposition
Jun 9, 2023
Grant Date
Nov 20, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3883606B9 was granted on Nov 20, 2024 by Janssen Biotech The patent is currently Granted And Under Opposition.

đŸ“œ Patent Opposition Countdown

Patent Grant Date: Nov 20, 2024

Opposition Deadline: Aug 20, 2025

178

days remaining to file oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREApr 12, 2024WITHDRAWN
KARO PATENTANWALTE KAHLHOFER ROSSLER KREUELS PARTG MBBApr 11, 2024ADMISSIBLE
BIOCON BIOLOGICSApr 8, 2024WITHDRAWN
SAMSUNG BIOEPIS NLFeb 5, 2024ADMISSIBLE
CAMULONJul 27, 2023WITHDRAWN

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2009181027
N/A
OppositionWO2017112536
N/A
OppositionUS6902734
N/A
OppositionUS7166285
N/A
OppositionWO2020065532
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.